Eversept Partners, LP Glaukos Corp Transaction History
Eversept Partners, LP
- $993 Million
- Q2 2025
A detailed history of Eversept Partners, LP transactions in Glaukos Corp stock. As of the latest transaction made, Eversept Partners, LP holds 31,496 shares of GKOS stock, worth $2.5 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
31,496
Previous 158,957
80.19%
Holding current value
$2.5 Million
Previous $15.6 Million
79.21%
% of portfolio
0.33%
Previous 1.73%
Shares
2 transactions
Others Institutions Holding GKOS
# of Institutions
329Shares Held
54.3MCall Options Held
259KPut Options Held
481K-
Black Rock Inc. New York, NY8.04MShares$639 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$486 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$258 Million0.06% of portfolio
-
State Street Corp Boston, MA2.09MShares$166 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2MShares$159 Million0.05% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $3.78B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...